Combination of HCV NS3 protease inhibitor with interferon and ribavirin

Details for Australian Patent Application No. 2009293493 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Huang, David; Steinmann, Gerhard Gustav; Stern, Jerry O.

Agent Spruson & Ferguson

Pub. Number AU-A-2009293493

PCT Pub. Number WO2010/033443

Priority 61/109,033 28.10.08 US; 61/097,753 17.09.08 US; 61/171,935 23.04.09 US

Filing date 14 September 2009

Wipo publication date 25 March 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/033443 Priority application(s): WO2010/033443

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293494-Crystalline forms of a 2-thiazolyl4-quinolinyl-oxy derivative, a potent HCV inhibitor

2009293492-Processes for the synthesis of five and six membered heterocyclic rings